|
|
|
|
Circumcision originated for the express purpose of depriving a
man of the incredible sexual pleasure his foreskin was designed
to produce. Despite the slight-of-hand attempts doctors make at
confusing the issue with medical myths and lies, circumcision
continues to be done for precisely this reason. But there is another force driving the circumcision machinery, and it is an even more insidious one. MONEY. The numbers of dollars involved are staggering, and this financial force is one which is providing the funds to continue the spread of medical propaganda advocating circumcision. A number of high-tech businesses know unequivocally that infant foreskin is extraordinarily unique. Companies such as Apligraf, Advanced Tissue Sciences, BioSurface Technology, Ortec International, and Organogenisis (and many others) are huge purchasers of infant foreskin tissue. The May 1998 issue of Business Week provided a glimpse into this sadistic industry. "One piece of foreskin can produce four acres of engineered skin". Skin that sells for more than $3,000.00 a square foot! The February 1998 issue of Wired magazine quotes one of these companies, "The cells from a single foreskin can produce 200,000 units of manufactured skin". "That's enough skin to cover about 250 people." Other companies also know the value of infant foreskin. Cosmetics companies, such as Estee Lauder, Helene Curtis, and Mary Kay Cosmetics, use babies' foreskins in their test laboratories. |
|
The doctors aren't going to put an end to circumcision - they make
huge sums of money to mutilate the babies. The hospitals aren't
going to put an end to it - they get paid when they sell the
foreskins to the cosmetics and biotech companies. Those commercial
companies aren't going to put an end to it - they're making mountains
of money churning out commercial consumer products from the tortured
suffering of innocent babies. And the government isn't going to stop
it - they make money off the product licensing approval fees and the
taxes on all the various and sundry 'sales'. |
|
|
|
Related reference articles (in no particular order): Periscope: Bionic Band-Aid Newsweek Wednesday, January 13, 1999 Living Human Skin Equivalent Apligraf Molecule of the Month February 1998 Bioengineered skin wins approval from the FDA Wound Care newsletter July 1998 The Role of Tissue Engineering in Wound Care AVF Newsletter American Venous Forum, Winter 1998 Media Release - Communique Aux Medias - Medienmitteilung FDA clears Apligraf (graftskin) for venous leg ulcers 26 May 1998 FDA approves new bioengineered skin The Associated Press Cleveland Live, May 27, 1998 FDA Clears Apligraf™ (graftskin) for Venous Leg Ulcers Novartis Pharmaceuticals Corporation May 26 1998 New Skin Mining Co. Guide January 14, 1999 Apligraf Organogenisis Inc. Organogenesis Inc. may buy back 500,000 shares Boston Business Journal September 14, 1998 Artificial Skin Biomedical Engineering: University of Southern California May 1998 Canada Becomes First Country To Approve Apligraf Tissue Newswire April 1997 Lending a hand: Biotech firm sells body parts The Ottawa Citizen Monday 16 February 1998 Biotech Bodies Business Week July 16, 1998 Biotech Devices Promise Benefits in Wound Repair and Surgery Medical Device & Diagnostic Industry Magazine February 1997 Special report on the tissue engineering and wound healing symposium at the Joint PAN/Asian and ETRS Meeting, 28 - 31 October 1997 European Tissue Repair Society 27 July 1998 FDA panel urges approval of bioengineered skin C-Health News Thursday, January 29, 1998 |
 |
Copyright ©1997-1999 WebMagician - All Rights Reserved last updated: March 7, 1999 |
WebSite Design by |
